<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02310204</url>
  </required_header>
  <id_info>
    <org_study_id>10 141 01</org_study_id>
    <nct_id>NCT02310204</nct_id>
  </id_info>
  <brief_title>Therapeutic Education Program in Psoriasis</brief_title>
  <acronym>EDUPSO</acronym>
  <official_title>Evaluation of a Therapeutic Education Program in Patients With Moderate to Severe Psoriasis : a Multicenter Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this research protocol is to assess the effect of a structured
      therapeutic education program on the quality of life of patients with moderate to severe
      psoriasis
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Psoriasis is a chronic inflammatory skin disease affecting 1 to 3% of the French population.
      Moderate to severe psoriasis has a significant impact on quality of life. Psoriasis is
      associated with an increased risk of depression, social isolation, unemployment. In addition,
      it has recently be shown that patients with moderate to severe psoriasis have an increased
      incidence of cardiovascular risk factors such as hypertension, overweight, hyperlipidemia and
      exposure to tobacco and alcohol. These so-called comorbidites may have a negative impact on
      psoriasis management. They also may account for the reduced life expectancy reported in
      patients with severe psoriasis. Therapeutic education is a structured process whose objective
      is to help patients to acquire or to maintain competencies that are required to live with a
      chronic disease. Therapeutic education is an important process to be integrated into the
      therapeutic strategy. It has to take into account co-morbidities, social and psychological
      context and its priorities need to be defined with the patient.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>skindex quality of life</measure>
    <time_frame>3 months</time_frame>
    <description>evaluation of quality of life</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>SF36 - Short Form 36</measure>
    <time_frame>3 MONTHS</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PASI - Psoriasis Area and Severity Index</measure>
    <time_frame>3 MONTHS</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">187</enrollment>
  <condition>Psoriasis</condition>
  <arm_group>
    <arm_group_label>multidisciplinary education program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>individual and group education sessions over a 6-month period</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard psoriasis care alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard psoriasis care alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>multidisciplinary education program</intervention_name>
    <description>both individual and group education sessions over a 6-month period in addition to standard psoriasis care</description>
    <arm_group_label>multidisciplinary education program</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard psoriasis care alone</intervention_name>
    <arm_group_label>Standard psoriasis care alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Moderate to severe psoriasis defined as patients receiving a systemic psoriasis
             treatment including methotrexate, cyclosporine, PUVA, retinoids or a biological agent
             and with significant impact on quality of life defined as a Skindex &gt; 18

          -  Patients with palmo-plantar or erythrodermic psoriasis may be included if they can be
             classified as moderate to severe according the above described definitions

        Exclusion Criteria:

          -  Patients not able to give informed consent,

          -  Patients not able to follow the program,

          -  Patients without social security affiliation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carle PAUL, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <zip>69437</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unversity Hospital</name>
      <address>
        <city>Lyon</city>
        <zip>69437</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Timone Hospital</name>
      <address>
        <city>Marseille</city>
        <zip>13000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Joseph Hospital</name>
      <address>
        <city>Marseille</city>
        <zip>13008</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Archet Hospital</name>
      <address>
        <city>Nice</city>
        <zip>6000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint-Louis Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Haut Leveque Hospital</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Viguier M, Livideanu C, Beylot-Barry M, Richard MA, Paul C, Bachelez H, Aubin F; Groupe de Recherche sur le Psoriasis. Observational case series on a group of psoriasis patients who failed to respond to any TNF blockers. J Dermatolog Treat. 2014 Feb;25(1):75-7. doi: 10.3109/09546634.2013.806766. Epub 2013 Jun 20.</citation>
    <PMID>23724854</PMID>
  </reference>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 1, 2014</study_first_submitted>
  <study_first_submitted_qc>December 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2014</study_first_posted>
  <last_update_submitted>December 5, 2014</last_update_submitted>
  <last_update_submitted_qc>December 5, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 8, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psoriasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

